Clinical Trials

200 enrolled

Adenoma, Islet Cell

NCT07328607 2026-01-21

Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy

90 enrolled

Adenoma, Islet Cell

NCT04520932 2025-05-25

RFANET

82 enrolled

Adenoma, Islet Cell

NCT05037461 2024-12-18

PRIME

Endocrine

Adenoma, Islet Cell, Multiple Endocrine Neoplasia Type 1

NCT06024343 2024-11-07

Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Exposure, Repair or Reconstruction

Phase NA Completed

230 enrolled

Phase NA Not yet recruiting

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT06167421 2023-12-12

Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy

240 enrolled

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT05566093 2022-10-04

EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors

Non functioning pancreatic endocrine tumor, Adenoma, Islet Cell

NCT05554744 2022-09-27

EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors

Endocrine

Adenoma, Islet Cell, Multiple Endocrine Neoplasia Type 1

NCT03435770 2018-02-20

Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms

10 enrolled

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT03417843 2018-02-13

yes

Adenoma, Islet Cell, Pancreatic Cyst, Pancreatic Neoplasms

NCT00730483 2017-08-25

Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors

Phase NA Terminated

13 enrolled 5 charts

Endocrine

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Neoplasm Metastasis, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

NCT00671463 2013-06-11

LEAPS

Phase NA Withdrawn